Caris Life Sciences, Inc.

Caris Life Sciences, Inc.

CAI·NASDAQ

$15.48

-1.5%
HealthcareBiotechnology

Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and machine learning algorithms. The company's molecular profiling services portfolio includes MI Profile, a tissue-based molecular profiling solution; and Caris Assure, a blood-based molecular profiling solution for cancer treatment. It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers. The company was founded in 2008 and is headquartered in Irving, Texas.

At a Glance

Live Snapshot
Market Cap$4.38B
EPS-1.9000
P/E Ratio-8.15
Earnings Date06/03/2026

cai

Interest Expense

Last Annual Value

56.85M

3-Year CAGR

29%

5-Year CAGR

-6%

10-Year CAGR

5%

Caris Life Sciences, Inc.

Caris Life Sciences, Inc. Competitors Analysis of Interest Expense

CAI · NASDAQ
CompanyInterest Expense
CAGR 3Y
CAGR 5Y
CAGR 10Y
56.85M
21.6%N/A2.9% 
MRNA logo
Moderna, Inc.
NASDAQ:MRNA
0.00
N/AN/AN/A
0.00
N/AN/AN/A
103.87M
21.7%28.8%46.8%
0.00
N/AN/AN/A
22.31M
20.6%N/A34.4%
195.05M
-12.3%-6.9%12.2%
18.13M
-1.1%19.2%-1.0%
20.58M
14.0%N/AN/A
Caris Life Sciences, Inc.

Caris Life Sciences, Inc. Fair Value Envelope

CAI · NASDAQ

Our analysis suggests that CAI has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $15.48, this represents a potential HIDDEN relative to our calculated worth for Caris Life Sciences, Inc..

Intrinsic Value
Current Price: $15.48